Structure-based identification and characterisation of novel inhibitors of KNa1.1 potassium channels, a stratified target for KCNT1-related epilepsy.
B. A. Cole, R. M. Johnson, H. Dejakaisaya, N. Pilati, C. W. G. Fishwick, S. P. Muench, J. D. Lippiat
This study identifies novel inhibitors of KNa1.1 potassium channels using cryo-EM structures and computational methods, showing improved potency over quinidine for KCNT1-related epilepsy treatment.
bioRxiv · Sep 26, 2019Pharmacology & Toxicology